Concepedia

Justine Maltby

JM

Statistics

Publications

6

Citations

276

H-Index

6

Active since

2009

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (United States)

Loughborough University

AstraZeneca (Sweden)

Karolinska Institutet

Justine Maltby is an author at AstraZeneca (United Kingdom) specializing in pharmacology, medicine, and neuropharmacology.

Publications per year

2009–2016

6

Publications

6

Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental Chronic Obstructive Pulmonary Disease

Andrew Churg, Caroline Marshall, Don D. Sin et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 107 citations

, , +16

AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease

Gvido Cebers, Robert Alexander, Samantha Budd Haeberlein et al. · Journal of Alzheimer s Disease · 2016 · 87 citations

, , +17

AZD3293 A novel BACE1 inhibitor: safety, tolerability, and effects on plasma and CSF Aβ peptides following single- and multiple-dose administration

Robert Alexander, Samantha L. Budd, Muir Russell et al. · Neurobiology of Aging · 2014 · 24 citations

, , +9

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848

Stephen Delaney, Mark Biffen, Justine Maltby et al. · BMJ Open Respiratory Research · 2016 · 21 citations · Full text

, , +16

E. coli expression and purification of human and cynomolgus IL-15

Alison Ward, Malcolm Anderson, Robert I. Craggs et al. · Protein Expression and Purification · 2009 · 20 citations

, , +13

1–5 of 6